|
|
Lysosomal Storage Disease
Get the facts on Lysosomal Storage Disease treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Lysosomal Storage Disease prevention, screening, research, statistics and other Lysosomal Storage Disease related topics. We answer all your qestions about Lysosomal Storage Disease.
Question: imagine that you are a pediatrician and one of your patient is a newborn who may have a lysosomal storage dise? disease. You remove some cells from the patient and examine them under the microscope. What would expect to see? Design a series of tests that reveal whether the patient is indeed suffering from a lysosomal storage disease.
Answer: Well you'd expect to see swollen cells with eccentric nuclei filled with the substance that is over-stored in the particular type of lysosomal storage disease present. However, you would have to have the right type of cells where the storage is occurring (again, the "right" type will depend on the specific disease). Finally, a pediatrician would rarely be the one obtaining the cells and would almost never be the one looking at the cells under the microscope. The one obtaining the cells would often be a consultant taking a biopsy and the one looking under the scope would be a pathologist.
That being said, a link to a picture is attached and you can get a lot more pictures if you Google: lysosomal storage disease histology
Question: Biology question 3..lysosomal disease? Imagine that you are a pediatrician and one of your patients is a newborn who may have a lysosomal storage disease. You remove some cells from the patient and examine them under the microscope. What would you expect to see? Design a series of tests that could reveal whether the patient is indeed suffering from a lysosomal storage disease.
Answer: So, first what is a lysosome? Lysosomes are special vesicles in the cells which store large amounts of acidic material. When the cell wants to destroy something, it is sent into the lysosome. The lysosome storage disease means that the lysosome is not breaking something down correctly, and because of this it builds up inside of the lysosome. You will therefore see enlarged or burst lysosomes when you look in the microscope.
Question: What would you expect to see? Imagine that you are a pediatrician and one of your patients are a newborn who may have lysosomal storage disease. You remove some cells from the patient and examine them under a microscope. What would you expect to see? Design a series of test that can reveal whether the patient is indeed suffering from a lysosomal storage disease.
Answer: http://www.lysosomallearning.com/healthc…
Question: What would expect to see? Imagine that you are a pediatrician and one of your patients is a newborn who may have a lysosomal storage disease. You remove some cells from the patient and examine them under the microscope. Design a series of test that could reveal whether the patient is indeed suffering from a lysosomal storage disease.
Answer: Hmm good question if it were me
I would first burn the specimen to see if anything would occur.
Well not burn just heat
We need to see if it would react to anything then attack the weakeness.
Another one u can do is freeze the specimen that would be a first stem too before examining.
Question: What would you expect to see? Imagine that you are a pediatrician and one of your patients is a newborn who may have a lysosomal storage disease. You remove some cells from the patient and examine them under the microscope. What would you expect to see? Design a series of tests that could reveal whether the patient is indeed suffering from a lysosomal storage disease.
Answer: Take this one to the health section.
Lysosomal Storage Disease News
|
|
|
|
New York Daily News
The workshop was conducted by the Lysosomal Storage Disorders Support Society (LSDSS) at the Maulana Azad Medical College to spread awareness about the rare disease. MPS is a group of genetic conditions wherein the absence or deficiency of an enzyme ...
|
| |
McPherson Sentinel
MPS is a rare genetic lysosomal storage disease caused by the body's inability to produce specific enzymes. This prevents a proper recycling process, resulting in progressive damage throughout the body, including the heart, bones, joints, ...
|
| |
MarketWatch (press release)
Angiochem is developing a focused product pipeline, including small molecules and biologics, for the potential treatment of a wide range of CNS diseases, including brain cancer, neurodegenerative and lysosomal storage diseases, pain, and others.
|
| |
MarketWatch (press release)
SBC-102 is being developed as an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, a lysosomal storage disorder (LSD), and is a recombinant form of the human LAL enzyme. SBC-102 is currently being evaluated in global clinical ...
|
| |
MarketWatch (press release)
In addition to the ongoing work in Fabry, Amicus is investigating chaperone-ERT combinations as potential next-generation treatments for Pompe, Gaucher, and other undisclosed lysosomal storage diseases where the Company believes there are significant ...
|
| |
Newstrack India
The workshop was conducted by the Lysosomal Storage Disorders Support Society (LSDSS) at the Maulana Azad Medical College to spread awareness about the rare disease. MPS is a group of genetic conditions wherein the absence or deficiency of an enzyme ...
|
| |
Although solutions to unusual diseases are rare, some therapies hold hope
Daily Mail
|
| |
GlobeNewsWire (press release)
In addition to the ongoing work in Fabry, Amicus is investigating chaperone-ERT combinations as potential next-generation treatments for Pompe, Gaucher, and other undisclosed lysosomal storage diseases where the Company believes there are significant ...
|
| |
EON: Enhanced Online News (press release)
SBC-102 is being developed as an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, a lysosomal storage disorder (LSD), and is a recombinant form of the human LAL enzyme. SBC-102 is currently being evaluated in global clinical ...
|
| |
Deccan Herald
In many cases, they attribute the problem to other disorders, resulting in crucial delay in diagnosis and treatment of patients.? Experts at the workshop, organised by the Lysosomal Storage Disorders Support Society, said early diagnosis is crucial and ...
|
| |
|
|